Minister Aurelijus Veryga has been central to discussions concerning the implementation of state-owned pharmacies. Critics, however, have voiced significant reservations regarding the proposed structure and its economic impact. According to V.
Čmilytė-Nielsen, the leader of the opposition Liberal Union, the assertion that this model will reduce medicine costs appears unsound. She characterized the move as representing yet another restriction on market competition and a substantial level of state intervention within the healthcare sector. Speaking to “Žinių radijas” on Friday, Čmilytė-Nielsen stated that the opposition hopes these specific plans will not be put into effect.
She emphasized the need for greater transparency from the government regarding the objectives behind such initiatives. She indicated that the opposition intends to seek clarification from L. Kukuraitis concerning the precise goals and anticipated outcomes of these proposals.
“We see this very clearly in the field of health care,” she remarked, adding that while she hopes the current plans will not proceed, the opposition will certainly address the underlying purpose and expected results with the relevant minister. The critique centers on the perceived overreach of government control, suggesting that such centralized measures may undermine existing market efficiencies rather than improve them. The debate highlights a continued political disagreement over the optimal model for managing pharmaceutical distribution within the country.
Topics: #state #another #plans
